MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismmiRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarksMicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.Identification of microRNAs associated with glioma diagnosis and prognosis.Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathwaymiR-132/212 cluster inhibits the growth of lung cancer xenografts in nude mice.miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expressionChanges in apoptotic microRNA and mRNA expression profiling in Caenorhabditis elegans during the Shenzhou-8 missionmiR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancerMicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancerEstrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin αV expression.The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2.MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1.miRNAs: micro-managers of anticancer combination therapies.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab.MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells.Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas.MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK.MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1.High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
P2860
Q26747273-01BE39F1-48B3-4929-90E2-63C5B71C70E3Q26774456-703C0DF5-8913-4EC0-8E57-25C8CEF91E92Q26781836-5C4E74F7-DC46-4123-BBCE-253B7BAF0502Q33622710-240EFD43-E2F7-4492-A9A7-644986DB359BQ33688677-96578AAE-F6A1-4A73-B113-001413881774Q33784380-4B353D60-BC41-474B-8521-5C2A03DEFC24Q34769868-E9E453F3-62CD-40E7-B66D-7064E7DACB6EQ36132797-9B9FEE14-50EF-4454-9440-3EE5C86BAC8BQ36213516-C75BA235-CC58-40E3-A573-E067A8589AE5Q36234746-678E12FE-72D1-49A4-A4A5-D7D684AEE493Q36300089-23797916-69B4-4A1C-A9FC-DC3BAFEA75C9Q36504303-01EE17D9-7561-4FC2-B867-D88BB2018B5FQ37098282-23CA4143-248B-4B1E-9DB6-1FE7DF579FB0Q37190423-8BDADE4C-74CA-4ABF-AA6D-725481910D54Q37392880-C42973F3-5EF1-42AA-8D77-9B1579E8A56AQ37589647-5CC702F9-4C96-4A2F-8B77-E247F4631AFDQ37596822-0F4E672D-DA21-4F80-8A58-31DF4DFA6BCAQ38546133-6EEA7D74-6E96-495F-9D4C-F9645269C20EQ38703769-81204DC4-0A05-4C4E-AAC0-F62F356E327CQ38774889-2DD84BD8-88D8-407D-8362-3156AE623F27Q38787321-234C506D-5774-4AC9-9EF2-473EC977DB90Q38840573-3519C889-B7F4-4CD2-9CFC-1477966096B2Q38904125-1BC7587F-6989-424B-B155-AF6EBB4D9159Q38952149-5A374F2D-92C1-4E9A-8466-A9FF5FC93CDDQ39285150-7856B869-3743-452D-A6F4-418DDC572F1AQ39368829-4614FE2C-0894-416E-9A95-07638C8DA319Q39616746-04A2ECD1-D31D-4BC2-9DE8-AB30D34B4556Q40555616-AD041A58-A8F6-47DD-93BA-327311DAFE07Q41686929-5A0B9D57-AA87-4F37-9281-791D61CFEAC1Q41811204-84050D5C-03A1-4D94-BC6E-CCF477E85452Q42378507-7B506E7A-D294-4524-B0E4-53C4830B312BQ42659697-80027D5A-DB96-4D0B-955E-748F5DCB0EC9Q43074397-3A2824F6-DD62-4AED-9FB8-BA28EE0F505AQ46791320-8D53D342-5EA7-487D-9AC7-4387D52CF09EQ47103533-A48E1765-154A-4B2F-B0C5-B1D499CDB86CQ47109964-011F4DEE-50C1-4932-AEF1-205FB2A623EDQ47221572-FB56700B-509E-4750-8A60-AAD5E2E2787EQ47246248-490A38EC-9391-4A0C-B7FE-E1A8B4F59B74Q47606186-F788AE17-DE8D-4053-8431-64B36E28EF97Q48597370-7DE8447A-4E16-4F86-AF28-4F021A7BA67B
P2860
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@ast
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@en
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@nl
type
label
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@ast
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@en
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@nl
prefLabel
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@ast
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@en
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@nl
P2093
P2860
P356
P1433
P1476
MiR-124 governs glioma growth ...... y by targeting R-Ras and N-Ras
@en
P2093
Chengfei Jiang
Chongyong Li
Chunsheng Kang
Qiudan Chen
Xiefeng Wang
P2860
P304
P356
10.1093/NEUONC/NOU084
P577
2014-05-25T00:00:00Z